Health

Health
What we know — and don't know — about the FDA-approved postpartum depression pill
Postpartum depression affects as many as 1 in 7 women in the U.S., though there are just two treatments approved for it. Experts say the newest could be a game-changer — depending on its price tag.
Southern Minnesota city lifts boil water advisory
The city of Eagle Lake, Minn. — just east of Mankato — asked residents and businesses earlier this week to boil water from the municipal water system after a power outage led to a drop in water pressure.
What the U.S. could learn from Japan about making healthy living easier
On a trip back to her parents' native country, a writer rediscovers what makes it different. The urban design, and a culture that values longevity, make good health come al lot more naturally.
The FDA approves the first pill specifically intended to treat postpartum depression
The Food and Drug Administration granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.